Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancer
Shejuan An(Northwestern University), Yi‐Long Wu(Guangdong General Hospital)
Cited by 14
Related Papers
Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status
|Journal of Hematology & Oncology|2015|89
The Unique Characteristics of MET Exon 14 Mutation in Chinese Patients with NSCLC
|Journal of Thoracic Oncology|2016|67
miR-144-3p, a tumor suppressive microRNA targeting ETS-1 in laryngeal squamous cell carcinoma
|Oncotarget|2016|43
Histone tail analysis reveals H3K36me2 and H4K16ac as epigenetic signatures of diffuse intrinsic pontine glioma
|Journal of Experimental & Clinical Cancer Research|2020|37